FDA approves Pfizer COVID-19 vaccine
A Food and Drug Administration advisory panel approved of broad distribution of the Pfizer COVID-19 vaccine, the Wall Street Journal reports.
Pfizer and Biotech said in a statement that they hope to see their vaccine be potentially available by mid-to-late December.
Moderna intends to submit for an Emergency Use Authorization (EUA) with the U.S. Food and Drug Administration (FDA) in the coming weeks. Moderna also plans to apply for authorization from global regulatory agencies.
During a speech update on Operation Warp Speed from the Rose Garden, President Donald Trump announced that the White House won't be delivering the COVID-19 vaccine to the state of New York unless authorized because Gov. Andrew Cuomo doesn't trust the current administration.
Trudeau called the news "encouraging," but pointed to record highs in cases across Canada, including in Ontario, which saw 1,328 new cases announced on Mondays.
The subject, a 28-year old man from Rio de Janeiro, died after not receiving the vaccine—instead having received a placebo as a part of a control group.